We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

118 hedge funds and large institutions have $59.7M invested in Sanofi Contingent Value Rights in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $57.3M → $59.7M (+$2.43M)

5% less funds holding

Funds holding: 124 → 118 (-6)

33% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 21

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

Holders
118
Holders Change
-6
Holders Change %
-4.84%
% of All Funds
3.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
14
Reduced
21
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Whitebox Advisors
Minnesota
+$2.53M
2
BPGAM
BTG Pactual Global Asset Management
Bermuda
+$388K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$160K
4
Allianz Asset Management
Allianz Asset Management
Germany
+$89.1K
5
SFM
Sphera Funds Management
Israel
+$33K

Top Sellers

Rank Fund Capital Flow
1
MFP
Michael F. Price
-$1.94M
2
SM
Scoggin Management
New York
-$1M
3
OAM
Oxford Asset Management
United Kingdom
-$904K
4
JGC
J. Goldman & Co
New York
-$200K
5
GI
GAMCO Investors
Connecticut
-$125K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Whitebox Advisors
Minnesota
$13.5M +$2.53M +5,218,360 +22%
FTCM
2
Fir Tree Capital Management
New York
$8.88M – – –
SFM
3
Sphera Funds Management
Israel
$7.69M +$33K +67,960 New
MCM
4
Mason Capital Management
New York
$7.07M – – –
GCM
5
Gruss Capital Management
New York
$3.92M – – –
CPM
6
Chesapeake Partners Management
Maryland
$3.66M +$2.9K +5,988 +0.1%
Allianz Asset Management
7
Allianz Asset Management
Germany
$2.85M +$89.1K +183,562 +3%
COPPSERS
8
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.48M – – –
CL
9
CSS LLC
Illinois
$1.28M – – –
NM
10
Newtyn Management
New York
$822K -$113K -232,200 -12%
Millennium Management
11
Millennium Management
New York
$733K +$18.5K +38,200 +2%
Citigroup
12
Citigroup
New York
$722K -$67 -139 -0%
Brown Advisory
13
Brown Advisory
Maryland
$661K -$279 -575 -0%
MFP
14
Michael F. Price
$594K -$1.94M -4,000,000 -76%
UOC
15
UBS O'Connor
Illinois
$559K – – –
PC
16
Pomelo Capital
New York
$488K – – –
SAM
17
Silverback Asset Management
North Carolina
$430K – – –
GF
18
Gabelli Funds
New York
$417K -$99.1K -204,200 -19%
BPGAM
19
BTG Pactual Global Asset Management
Bermuda
$372K +$388K +799,183 New
Adage Capital Partners
20
Adage Capital Partners
Massachusetts
$286K – – –
BMO
21
Beck Mack & Oliver
New York
$242K -$6.5K -13,400 -3%
ACM
22
Akanthos Capital Management
California
$233K – – –
Bank of America
23
Bank of America
North Carolina
$222K +$261 +538 +0.1%
TA
24
Teton Advisors
New York
$186K – – –
TL
25
TowerView LLC
New York
$186K – – –
1
2 3 4 5

GCVRZ Hedge Fund Activity: Q3 2014 in Review

118 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2014, worth a combined $59.7M — up 4.2% from $57.3M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 10 opened new positions — a net loss of 6 holders — while 21 trimmed existing stakes and 14 added.

The largest buyer was Whitebox Advisors, adding an estimated $2.53M. The largest seller was Michael F. Price, cutting an estimated $1.94M.

  • 118 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2014, down from 124 in Q2 2014.
  • Funds reported $59.7M of Sanofi Contingent Value Rights stock for Q3 2014, up 4.2% quarter-over-quarter.
  • 10 funds opened new Sanofi Contingent Value Rights positions in Q3 2014 and 16 closed out, a net change of -6 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2014 was Whitebox Advisors, an estimated $2.53M added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2014 was Michael F. Price, an estimated $1.94M sold.

Based on aggregated 13F filings for Q3 2014.